Spartacus Acquisition C – Market Update (Monday, 26 November 2026)
- Closing price (10:03 AM Central Europe): USD 10.02
- Price change during the 24‑hour period: +0.1 %
- Trading volume (last 24 h): USD 12.1 million worth of shares
- Shares outstanding: 23 million
- Market capitalization: USD 307.3 million
- Simple moving average (200 days): USD 10.02
- 52‑week high: USD 10.45 (recorded 04 July 2026)
- 52‑week low: USD 9.90 (recorded 04 June 2026)
- Performance relative to the previous month‑end: −0.1 %
Spartacus Acquisition C is currently trading at USD 10.02 on major exchanges. The share price has shown a modest increase during the 24‑hour period, but the stock is down 0.1 % compared with the previous month‑end close.
Comparison with Peer Stocks (24‑hour Performance)
| Stock | Ticker | 24‑hour change | Current price (USD) | Market cap (USD) | Notes |
|---|---|---|---|---|---|
| Citi Trends | CTRN | −1.28 % | 45.41 | 368.7 million | Price/earnings ratio: 52.29 |
| Alussa Energy Acquisit II | ALUB | +0.20 % | 10.15 | 364.8 million | Norwegian pharmaceutical firm reported encouraging interim results from a phase‑III study of its prostate‑cancer therapy; potential licensing extension may broaden market reach. |
| Siddhi Acquisition | SDHI | −0.09 % | 10.56 | 367.9 million | — |
| Cadiz | CDZI | +6.90 % | 4.34 | 367.1 million | Significant gain in the 24‑hour period. |
| Freedom Metals Acquisition | FDMMU | 0.00 % | 9.85 | 367.8 million | No change in price. |
Summary
Spartacus Acquisition C remains a mid‑cap company with a stable trading price at USD 10.02. The stock’s 24‑hour performance is modestly positive, though it has declined slightly relative to the month‑end. The company’s market capitalization is USD 307.3 million, with 23 million shares outstanding. Peer stocks exhibit varied performance, with Cadiz showing a substantial 6.9 % increase and Alussa Energy Acquisit II reporting promising clinical results that could influence its future valuation.